Shosaku Nomura Selected Research

Stable Angina

12/2006	Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
1/2004	Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome.
3/2003	Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shosaku Nomura Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 01/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 11/2002
16	Type 2 Diabetes Mellitus (MODY) 01/2018 - 05/2003
15	Multiple Myeloma 01/2022 - 04/2014
15	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 07/2002
13	Thrombosis (Thrombus) 07/2020 - 10/2005
12	Lung Neoplasms (Lung Cancer) 02/2019 - 01/2002
11	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 07/2005
9	Atherosclerosis 01/2015 - 11/2003
8	Hypertension (High Blood Pressure) 01/2016 - 04/2004
7	Rheumatoid Arthritis 01/2021 - 11/2012
6	Hemorrhage 01/2021 - 07/2002
6	Thrombocytopenia (Thrombopenia) 01/2012 - 07/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2003
5	Exanthema (Rash) 12/2020 - 04/2006
5	Inflammation (Inflammations) 11/2019 - 12/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 02/2004
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014 - 03/2009
4	Infections 09/2022 - 03/2004
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2005
4	Disseminated Intravascular Coagulation 01/2018 - 01/2011
4	Lymphoma (Lymphomas) 01/2017 - 01/2002
4	Hyperlipidemias (Hyperlipidemia) 01/2012 - 05/2003
4	Hyperglycemia 01/2011 - 04/2004
3	Asthma (Bronchial Asthma) 01/2022 - 08/2019
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2020 - 01/2011
3	Colitis 10/2018 - 10/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2011
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2017 - 04/2007
3	Vascular System Injuries 11/2009 - 01/2008
3	Acute Coronary Syndrome 01/2009 - 03/2003
3	Stable Angina 12/2006 - 03/2003
2	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 12/2017
2	Pneumonia (Pneumonitis) 02/2022 - 06/2020
2	Arthritis (Polyarthritis) 01/2021 - 06/2011
2	Essential Thrombocythemia 07/2020 - 08/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2020 - 09/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2019 - 09/2017
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 05/2018

Drug/Important Bio-Agent (IBA)

15	RV 538 (PDMP)IBA 01/2019 - 02/2003
13	AdiponectinIBA 12/2015 - 09/2005
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
12	SelectinsIBA 01/2018 - 02/2003
11	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
11	Inosine Triphosphate (ITP)IBA 01/2021 - 07/2002
10	P-SelectinIBA 01/2018 - 07/2002
10	ChemokinesIBA 09/2009 - 11/2002
8	Chemokine CCL5IBA 11/2014 - 07/2002
7	Monoclonal AntibodiesIBA 01/2021 - 08/2003
7	oxidized low density lipoproteinIBA 03/2009 - 05/2003
6	AutoantibodiesIBA 01/2021 - 02/2009
6	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 07/2005
6	Rituximab (Mabthera)FDA Link 12/2017 - 04/2007
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2010
5	Pharmaceutical PreparationsIBA 07/2020 - 07/2005
5	Therapeutic UsesIBA 08/2019 - 05/2004
5	Bortezomib (Velcade)FDA Link 01/2019 - 01/2012
5	Cell Adhesion MoleculesIBA 09/2009 - 05/2003
4	Peptides (Polypeptides)IBA 01/2020 - 07/2002
4	Dasatinib (BMS 354825)FDA Link 01/2019 - 12/2017
4	Tyrosine Kinase InhibitorsIBA 01/2019 - 11/2011
4	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 04/2014
4	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2008
4	Dacarbazine (DIC)FDA LinkGeneric 01/2018 - 03/2004
4	Hemostatics (Antihemorrhagics)IBA 01/2018 - 01/2008
4	Eicosapentaenoic AcidIBA 01/2018 - 05/2003
4	Bevacizumab (Avastin)FDA Link 05/2017 - 12/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 04/2004
4	2- (4- methyl- 2,6- dinitroanilino)- N- methylpropionamide (MDMP)IBA 09/2009 - 02/2003
4	E-SelectinIBA 09/2009 - 05/2003
4	CD40 Ligand (CD40L)IBA 09/2009 - 11/2002
3	tocilizumab (atlizumab)FDA Link 01/2021 - 06/2011
3	CytokinesIBA 01/2021 - 01/2002
3	SteroidsIBA 01/2021 - 12/2010
3	mogamulizumabIBA 12/2020 - 02/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2005
3	Lipopolysaccharide ReceptorsIBA 01/2020 - 10/2003
3	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2011
3	NivolumabIBA 08/2018 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 05/2017 - 03/2013
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2009 - 09/2005
3	Gefitinib (Iressa)FDA Link 11/2006 - 10/2005
3	Annexin A5IBA 09/2005 - 05/2003
2	Antiviral Agents (Antivirals)IBA 09/2022 - 01/2010
2	eltrombopag FDA Link 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 07/2013
2	pomalidomideIBA 11/2020 - 05/2018
2	anagrelide (Agrylin)FDA LinkGeneric 07/2020 - 08/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 02/2019 - 08/2018

Therapy/Procedure

38	Therapeutics 01/2022 - 07/2002
18	Drug Therapy (Chemotherapy) 12/2019 - 01/2002
11	Stem Cell Transplantation 01/2021 - 01/2002
9	Hematopoietic Stem Cell Transplantation 09/2022 - 01/2012
4	Percutaneous Coronary Intervention 05/2010 - 10/2005
3	Aftercare (After-Treatment) 08/2018 - 02/2004
3	Transplantation 08/2015 - 01/2002
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2014